Pacira BioSciences, Inc. (NASDAQ: PCRX) Stock Information | RedChip

Pacira BioSciences, Inc. (NASDAQ: PCRX)


$18.5900
+0.0100 ( +0.22% ) 394.4K

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Market Data


Open


$18.5900

Previous close


$18.5800

Volume


394.4K

Market cap


$857.90M

Day range


$18.1960 - $18.8510

52 week range


$11.1640 - $34.7800

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jan 06, 2025
4 Insider transactions 1 Jan 06, 2025
4 Insider transactions 1 Jan 06, 2025
4 Insider transactions 1 Jan 06, 2025
4 Insider transactions 1 Dec 16, 2024
8-k 8K-related 19 Nov 06, 2024
10-q Quarterly Reports 97 Nov 06, 2024
4 Insider transactions 1 Nov 05, 2024
3 Insider transactions 2 Oct 23, 2024
8-k 8K-related 15 Oct 21, 2024

Latest News